Follow-Up Measures | Men | Women | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | % (n/N) | PRc | 95% CI | PRd | 95% CI | % (n/N) | PRc | 95% CI | PRd | 95% CI |
Daily Steps | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Low PA School | 27 (55/205) | 1.0 | Ref | 1.0 | Ref | 26 (68/263) | 1.0 | Ref | 1.0 | Ref |
   Med PA School | 23 (53/235) | 0.84 | (0.59–1.20) | 0.91 | (0.65–1.26) | 27 (71/267) | 1.03 | (0.73–1.45) | 1.00 | (0.75–1.34) |
   High PA School | 28 (77/278) | 1.03 | (0.74–1.44) | 1.09 | (0.79–1.50) | 28 (80/288) | 1.07 | (0.76–1.52) | 1.05 | (0.77–1.43) |
p trend | Â | 0.77 | Â | 0.48 | Â | Â | 0.68 | Â | 0.81 | |
Total PAb | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Low PA School | 22 (52/237) | 1.0 | Ref | 1.0 | Ref | 27 (86/321) | 1.0 | Ref | 1.0 | Ref |
   Med PA School | 23 (62/266) | 1.06 | (0.76–1.49) | 1.08 | (0.79–1.47) | 26 (87/336) | 0.97 | (0.72–1.29) | 0.95 | (0.74–1.24) |
   High PA School | 26 (79/305) | 1.18 | (0.84–1.66) | 1.22 | (0.90–1.66) | 28 (100/357) | 1.05 | (0.82–1.34) | 1.00 | (0.78–1.28) |
p trend | Â | 0.32 | Â | 0.19 | Â | Â | 0.71 | Â | 0.99 | |
LTPAb | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Low PA School | 30 (70/237) | 1.0 | Ref | 1.0 | Ref | 23 (73/321) | 1.0 | Ref | 1.0 | Ref |
   Med PA School | 23 (61/266) | 0.78 | (0.59–1.03) | 0.79 | (0.60–1.04) | 24 (80/336) | 1.05 | (0.80–1.36) | 1.10 | (0.84–1.44) |
   High PA School | 27 (83/305) | 0.92 | (0.70–1.22) | 0.92 | (0.71–1.20) | 26 (93/357) | 1.15 | (0.89–1.47) | 1.18 | (0.91–1.53) |
p trend | Â | 0.65 | Â | 0.57 | Â | Â | 0.29 | Â | 0.22 | |
Fitness | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Low PA School | 23 (43/190) | 1.0 | Ref | 1.0 | Ref | 26 (51/197) | 1.0 | Ref | 1.0 | Ref |
   Med PA School | 30 (68/229) | 1.31 | (0.90–1.92) | 1.41 | (1.00–1.97) | 22 (46/209) | 0.85 | (0.58–1.25) | 0.82 | (0.58–1.17) |
   High PA School | 23 (62/266) | 1.03 | (0.71–1.48) | 1.14 | (0.81–1.60) | 26 (61/235) | 1.00 | (0.70–1.43) | 0.98 | (0.72–1.35) |
p trend | Â | 0.98 | Â | 0.75 | Â | Â | 0.95 | Â | 0.90 |